Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy

PURPOSE: To develop a CT-based radiomic signature to predict biochemical recurrence (BCR) in prostate cancer patients after sRT guided by positron-emission tomography targeting prostate-specific membrane antigen (PSMA-PET). MATERIAL AND METHODS: Consecutive patients, who underwent (68)Ga-PSMA11-PET/...

Descripción completa

Detalles Bibliográficos
Autores principales: Spohn, Simon K. B., Schmidt-Hegemann, Nina-Sophie, Ruf, Juri, Mix, Michael, Benndorf, Matthias, Bamberg, Fabian, Makowski, Marcus R., Kirste, Simon, Rühle, Alexander, Nouvel, Jerome, Sprave, Tanja, Vogel, Marco M. E., Galitsnaya, Polina, Gschwend, Jürgen E., Gratzke, Christian, Stief, Christian, Löck, Steffen, Zwanenburg, Alex, Trapp, Christian, Bernhardt, Denise, Nekolla, Stephan G., Li, Minglun, Belka, Claus, Combs, Stephanie E., Eiber, Matthias, Unterrainer, Lena, Unterrainer, Marcus, Bartenstein, Peter, Grosu, Anca-L., Zamboglou, Constantinos, Peeken, Jan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250433/
https://www.ncbi.nlm.nih.gov/pubmed/36929180
http://dx.doi.org/10.1007/s00259-023-06195-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250433/
https://www.ncbi.nlm.nih.gov/pubmed/36929180
http://dx.doi.org/10.1007/s00259-023-06195-3

Ejemplares similares